Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDArriVent BioPharma Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 4 | -$0.95 | -$0.88 | -$0.92 |
| Q2 2026 | 1 | -$0.96 | -$0.96 | -$0.96 |
| Q3 2026 | 1 | -$1.02 | -$1.02 | -$1.02 |
| Q4 2026 | 1 | -$1.04 | -$1.04 | -$1.04 |
ArriVent BioPharma Inc. Earnings Date And Information
ArriVent BioPharma Inc. last posted its earnings results on Monday, November 10th, 2025. The company reported $-0.83 earnings per share for the quarter, missing analysts' consensus estimates of $-0.78 by $0.05. The company had revenue of 0 for the quarter and had revenue of 0 for the year. ArriVent BioPharma Inc. has generated $-3 earnings per share over the last year ($-2.56 diluted earnings per share) and currently has a price-to-earnings ratio of -5.01. ArriVent BioPharma Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 2nd, 2026 based on prior year's report dates.
ArriVent BioPharma Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/10/2025 | Q3 2025 | -$0.78 | -$0.83 | -0.05 | $0 | $0 |
| 08/11/2025 | Q2 2025 | -$0.70 | -$0.90 | -0.2 | N/A | $0 |
| 05/12/2025 | Q1 2025 | -$0.66 | -$1.90 | -1.24 | N/A | $0 |
| 03/03/2025 | Q4 2024 | -$0.78 | -$0.61 | 0.17 | N/A | $0 |
| 11/14/2024 | Q3 2024 | -$0.82 | -$0.61 | 0.21 | N/A | $0 |
| 08/14/2024 | Q2 2024 | -$0.65 | -$0.65 | 0 | $1.33 M | $0 |
| 05/08/2024 | Q1 2024 | -$0.84 | -$0.52 | 0.32 | N/A | $0 |
| 03/28/2024 | Q4 2023 | N/A | -$0.63 | N/A | N/A | $0 |
| 09/29/2023 | Q3 2023 | N/A | -$0.43 | N/A | N/A | $0 |
| 06/29/2023 | Q2 2023 | N/A | -$0.64 | N/A | N/A | $0 |
| 03/30/2023 | Q1 2023 | N/A | -$0.36 | N/A | N/A | $0 |
| 12/30/2022 | Q4 2022 | N/A | -$0.31 | N/A | N/A | $0 |
| 09/28/2022 | Q3 2022 | N/A | -$0.35 | N/A | N/A | $0 |
| 06/30/2022 | Q2 2022 | N/A | -$5.76 | N/A | N/A | $0 |
| 03/31/2022 | Q1 2022 | N/A | -$5.76 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
ArriVent BioPharma Inc. Earnings: FAQ's
ArriVent BioPharma Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 2nd, 2026 based offlast year's report dates.
The conference call for ArriVent BioPharma Inc.'s latest earnings report can be listened to online.
The conference call transcript for ArriVent BioPharma Inc.'s latest earnings report can be read online.
ArriVent BioPharma Inc. (:AVBP) has a recorded net income of $-80,488,000.ArriVent BioPharma Inc. has generated $-2.56 earnings per share over the last four quarters.
ArriVent BioPharma Inc. (:AVBP) has a price-to-earnings ratio of -5.01 and price/earnings-to-growth ratio is 0.76.